Stocks
Anika Therapeutics (ANIK) FCF conversion US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | 5 years average | |||
| FCF conversion, % | -78.2% | -16.9% | -47.9% | -77.2% | -121.9% | -15.7% | |||
| Changes by years, y/y, % | +1 061pp | +61pp | -31pp | -29pp | -45pp | -68% | |||
Anika Therapeutics. FCF conversion, %
Anika Therapeutics. FCF conversion, changes, pp
Anika Therapeutics (ANIK) FCF conversion US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| FCF conversion, % | 67.2% | -596.1% | 191.6% | 183.9% | -43.7% | -15.7% | ||
| Changes by years, y/y, % | +1 870pp | -583pp | +191pp | +74pp | -111pp | |||
| Changes by quarters, q/q, % | -43pp | -663pp | +788pp | -8pp | -228pp | |||
